Clinical Trial Update: The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI) [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluated the efficacy and safety of donepezil hydrochloride in individuals with mild cognitive impairment and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Eisai Inc. | Conditions: Memory Loss | Phase 4 | Status: COMPLETED